20 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34365218 | Predicting response to platinum and non-platinum drugs through bioluminescence resonance energy transfer (BRET) based bio-molecular interactions in platinum resistant epithelial ovarian cancer. | 2021 Nov | 1 |
2 | 32431514 | Tetrandrine Reverses Paclitaxel Resistance in Human Ovarian Cancer via Inducing Apoptosis, Cell Cycle Arrest Through β-Catenin Pathway. | 2020 | 3 |
3 | 32660221 | Evaluation of miR-34a Effect on CCND1 mRNA Level and Sensitization of Breast Cancer Cell Lines to Paclitaxel. | 2020 Nov | 1 |
4 | 30244336 | Paclitaxel resistance and the role of miRNAs in prostate cancer cell lines. | 2019 Jun | 1 |
5 | 31206033 | miR-107 Enhances the Sensitivity of Breast Cancer Cells to Paclitaxel. | 2019 | 2 |
6 | 31467112 | Breast Cancer Risk-Associated SNPs in the mTOR Promoter Form De Novo KLF5- and ZEB1-Binding Sites that Influence the Cellular Response to Paclitaxel. | 2019 Nov | 3 |
7 | 30101722 | Anticancer Mechanism of Lobaplatin as Monotherapy and in Combination with Paclitaxel in Human Gastric Cancer. | 2018 | 1 |
8 | 30326563 | BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression. | 2018 Oct 15 | 1 |
9 | 27090655 | Vascular endothelial growth factor A as predictive marker for mTOR inhibition in relapsing high-grade serous ovarian cancer. | 2016 Apr 18 | 1 |
10 | 27095936 | Reduced BCL2 and CCND1 mRNA expression in human cervical cancer HeLa cells treated with a combination of everolimus and paclitaxel. | 2016 | 4 |
11 | 25633416 | 3,3'-Diindolylmethane potentiates paclitaxel-induced antitumor effects on gastric cancer cells through the Akt/FOXM1 signaling cascade. | 2015 Apr | 1 |
12 | 25849888 | β-Catenin expression is regulated by an IRES-dependent mechanism and stimulated by paclitaxel in human ovarian cancer cells. | 2015 May 22 | 2 |
13 | 26370682 | OVEREXPRESSION OF BOTH CLOCK AND BMAL1 INHIBITS ENTRY TO S PHASE IN HUMAN COLON CANCER CELLS. | 2015 | 1 |
14 | 23792647 | A CDK4/6 inhibitor enhances cytotoxicity of paclitaxel in lung adenocarcinoma cells harboring mutant KRAS as well as wild-type KRAS. | 2013 Jul | 1 |
15 | 24024333 | Effect of blocking Ras signaling pathway with K-Ras siRNA on apoptosis in esophageal squamous carcinoma cells. | 2013 Jun | 1 |
16 | 22949827 | Effects of cyclooxygenase inhibitors in combination with taxol on expression of cyclin D1 and Ki-67 in a xenograft model of ovarian carcinoma. | 2012 | 2 |
17 | 20883815 | Akt is upstream and MAPKs are downstream of NF-κB in paclitaxel-induced survival signaling events, which are down-regulated by curcumin contributing to their synergism. | 2011 Mar | 1 |
18 | 16243823 | Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. | 2005 Oct 15 | 1 |
19 | 12150453 | Overexpression of cyclin D1 enhances taxol induced mitotic death in MCF7 cells. | 2002 Jul | 5 |
20 | 9710718 | Unscheduled expression of cyclins by anti-cancer drug exposure. | 1998 Mar | 2 |